12 reports

  • 8.3.3 BRACHYTHERAPY ISOTOPES
  • 6.3.3 BRACHYTHERAPY ISOTOPES

The nuclear medicine market is projected to grow at a CAGR of 5.9% The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018. Factors such as the growing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99, are driving...

  • Brachytherapy
  • Energy
  • Healthcare
  • Nuclear Imaging Equipment
  • Nuclear Power

MARKET ##.

  • Brachytherapy
  • APAC
  • Europe
  • World
  • Company Sales
  • LDR BRACHYTHERAPY
  • HDR BRACHYTHERAPY

About Brachytherapy Devices Brachytherapy is a type of radiation therapy that involves the placement of radioactive material inside the patient body to treat cancer. It is also knowns as internal radiation. Technavio’s analysts forecast the Global Brachytherapy Devices Market to grow at a CAGR of 7.95% during...

  • Brachytherapy
  • Forecast
  • Carl Zeiss Meditec AG
  • Eckert & Ziegler AG
  • Varian Medical Systems, Inc.

Brachytherapy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2022 ##.

  • Biological Therapy
  • Brachytherapy
  • World
  • Market Shares

Brachytherapy Market Analysis By Type, By Application, By Region And Segment Forecasts, 2014 - 2025 Chapter ## Research Methodology ##. ## Information Procurement ##. ## Data Analysis Chapter ## Executive Summary Chapter ## Market Snapshot Chapter ## Brachytherapy Market Variables,

  • Biological Therapy
  • Brachytherapy
  • United States
  • Market Size
  • 6.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
  • 8.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY

Radiotherapy market projected to grow at a CAGR of 6.8%. The global radiotherapy market is expected to reach USD 9.47 billion by 2022 from USD 6.81 billion in 2017, at a CAGR of 6.8%. The rapidly increasing geriatric population, growing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy,...

  • Brachytherapy
  • Hospital
  • North America
  • United States
  • Market Size
  • NUCLEAR MEDICINE BRACHYTHERAPY GLOBAL MARKET SHARE, BY ISOTOPE, (2017) (%)
  • BRACHYTHERAPY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)

Over the past 50 years nuclear medicine field has displayed a strong link between investments in chemistry and development of radionuclides and radio-labeled compounds which has impacted the healthcare practice. Nuclear medicine comprises diagnostic and therapeutic techniques that use radioisotopes for applications...

  • Brachytherapy
  • World
  • Market Size
  • Cardinal Health, Inc.
  • Lantheus Medical Imaging, Inc.
  • ECKERT & ZIEGLER BEBIG TO ACQUIRE BRACHYTHERAPY BUSINESS OF BIOCOMPATIBLES FOR US$5 MILLION
  • ECKERT & ZIEGLER BEBIG ACQUIRES MICK RADIO NUCLEAR INSTRUMENTS, MANUFACTURER OF APPLICATORS FOR BRACHYTHERAPY

Summary Eckert & Ziegler BEBIG SA (Eckert & Ziegler), a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG is a medical device company that produces and distributes brachytherapy and radiotherapy products.The company offers products such as permanent prostate implants, HDR afterloaders, and ophthalmic applicators. Its...

  • Brachytherapy
  • United States
  • Company
  • M&A
  • Eckert & Ziegler AG
  • SEP 12, 2018: ISORAY: THREE RECENT PEER-REVIEWED PUBLICATIONS REINFORCE THE VALUE OF BRACHYTHERAPY AS A TREATMENT FOR PROSTATE CANCER
  • MAR 21, 2018: NEW STUDY REPORTS THAT COMBINATION TREATMENT WITH BRACHYTHERAPY YIELDS SIGNIFICANTLY BETTER OUTCOMES FOR MEN WITH AGGRESSIVE PROSTATE CANCER

Summary IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors.The company produced Cesium-131, a radioactive isotope used...

  • Brachytherapy
  • United States
  • Company Financials
  • Market Size
  • IsoRay, Inc.
  • INTERNATIONAL BRACHYTHERAPY PLANS TO ACQUIRE US COMPANY
  • ECKERT & ZIEGLER BEBIG TO ACQUIRE BRACHYTHERAPY BUSINESS OF BIOCOMPATIBLES FOR US$5 MILLION

Summary Eckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler) is a medical device company that provides isotope technology products. The company offers radiation therapy, isotope and radio-pharma products. It provides radiation therapy products for Brachytherapy, a minimally invasive procedure used as an effective treatment...

  • Brachytherapy
  • Medical Device
  • United States
  • M&A
  • Medizintechnik AG
  • JUN 19, 2018: ISORAY ANNOUNCES ENTRY INTO EMPLOYMENT AGREEMENT WITH LORI A. WOODS AS INTERIM CEO
  • AUG 04, 2017: ISORAY ANNOUNCES PRELIMINARY FOURTH QUARTER F2017 REVENUE OF $1.37 MILLION, 22% YEAR-OVER-YEAR INCREASE

Summary IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors.The company produced Cesium-131, a radioactive isotope used...

  • Brachytherapy
  • United States
  • Company Financials
  • Market Size
  • IsoRay, Inc.
  • EUROPEAN NUCLEAR MEDICINE PROCEDURAL VOLUME FOR BRACHYTHERAPY, BY TYPE, 2013-2020 (THOUSAND)
  • EUROPE: BRACHYTHERAPY ISOTOPES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)

The European nuclear medicine/radiopharmaceuticals market is segmented on the basis of type, application, and country. The European nuclear medicine/radiopharmaceuticals market is valued at USD 1.095 billion in 2015 and is poised to grow at a CAGR of 8.2% during the forecasted period. Factors such as increasing preference for SPECT...

  • Brachytherapy
  • Europe
  • World
  • Market Size
  • Bayer AG